5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats

By Balasubramaniam G.   Lee H.S.   Mah S.C.  

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 183-190

Elsevier

Access to resources Recommend Favorite

Effects of endothelin-1 on norepinephrine-induced vasoconstriction in deoxycorticosterone acetate-salt hypertensive rats

By Kita S.   Taguchi Y.   Chatani S.   Matsumura Y.  

European Journal of Pharmacology, Vol. 344, Iss. 1, 1998-02 ,pp. : 53-57

Elsevier

Access to resources Recommend Favorite

Effects of tetrandrine on left ventricle hypertrophy in deoxycorticosterone acetate-salt hypertensive rats

By Xu Y.   Rao M.-R.  

European Journal of Pharmacology, Vol. 278, Iss. 1, 1995-05 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite

Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats

By Majima M.   Ikeda Y.   Kuribayashi Y.   Mizogami S.   Katori M.   Aoyagi T.  

European Journal of Pharmacology, Vol. 284, Iss. 1, 1995-09 ,pp. : 1-11

Elsevier

Access to resources Recommend Favorite

Effect of exercise training on liver antioxidant status of deoxycorticosterone acetate salt induced hypertensive rats

By Elhaïmeur Fatiha   Courderot-Masuyer Carol   Nicod Laurence   Bobillier-Chaumont Sylvie   Robin Sophie   Richert Lysiane   Berthelot Alain  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 5, 2003-05 ,pp. : 469-475

NRC Research Press

Access to resources Recommend Favorite